212 related articles for article (PubMed ID: 2871050)
1. Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder.
Ciraulo DA; Barnhill JG; Boxenbaum HG; Greenblatt DJ; Smith RB
J Clin Pharmacol; 1986 Apr; 26(4):292-8. PubMed ID: 2871050
[TBL] [Abstract][Full Text] [Related]
2. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment.
Sheehan DV; Coleman JH; Greenblatt DJ; Jones KJ; Levine PH; Orsulak PJ; Peterson M; Schildkraut JJ; Uzogara E; Watkins D
J Clin Psychopharmacol; 1984 Apr; 4(2):66-75. PubMed ID: 6142907
[TBL] [Abstract][Full Text] [Related]
3. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
Rizley R; Kahn RJ; McNair DM; Frankenthaler LM
Psychopharmacol Bull; 1986; 22(1):167-72. PubMed ID: 2873609
[No Abstract] [Full Text] [Related]
4. Agoraphobia and panic disorder: treatment with alprazolam.
Mark SL
Tex Med; 1984 Oct; 80(10):50-2. PubMed ID: 6150561
[No Abstract] [Full Text] [Related]
5. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
Pyke RE; Greenberg HS
J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
[TBL] [Abstract][Full Text] [Related]
6. Taper withdrawal studies with alprazolam in patients with panic disorder and agoraphobia.
Pecknold JC; Swinson RP
Psychopharmacol Bull; 1986; 22(1):173-6. PubMed ID: 3726063
[No Abstract] [Full Text] [Related]
7. The relationship of alprazolam dose to steady-state plasma concentrations.
Ciraulo DA; Antal EJ; Smith RB; Olson DR; Goldberg DA; Rand EH; Raskin RB; Phillips JP; Shader RI; Greenblatt DJ
J Clin Psychopharmacol; 1990 Feb; 10(1):27-32. PubMed ID: 2407754
[TBL] [Abstract][Full Text] [Related]
8. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
Swinson RP; Pecknold JC; Kuch K
Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):105-13. PubMed ID: 3628823
[TBL] [Abstract][Full Text] [Related]
9. Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.
Greenblatt DJ; Harmatz JS; Shader RI
Arch Gen Psychiatry; 1993 Sep; 50(9):715-22. PubMed ID: 8357297
[TBL] [Abstract][Full Text] [Related]
10. Alprazolam in the treatment of panic disorders.
Liebowitz MR; Fyer AJ; Gorman JM; Campeas R; Levin A; Davies SR; Goetz D; Klein DF
J Clin Psychopharmacol; 1986 Feb; 6(1):13-20. PubMed ID: 2869059
[TBL] [Abstract][Full Text] [Related]
11. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
Munjack DJ; Crocker B; Cabe D; Brown R; Usigli R; Zulueta A; McManus M; McDowell D; Palmer R; Leonard M
J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490
[TBL] [Abstract][Full Text] [Related]
12. Benzodiazepines in panic disorder and agoraphobia.
Sheehan DV
J Affect Disord; 1987; 13(2):169-81. PubMed ID: 2890678
[TBL] [Abstract][Full Text] [Related]
13. Alprazolam treatment for panic disorders.
Alexander PE; Alexander DD
J Clin Psychiatry; 1986 Jun; 47(6):301-4. PubMed ID: 2872205
[TBL] [Abstract][Full Text] [Related]
14. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.
Lesser IM; Lydiard RB; Antal E; Rubin RT; Ballenger JC; DuPont R
Am J Psychiatry; 1992 Nov; 149(11):1556-62. PubMed ID: 1415824
[TBL] [Abstract][Full Text] [Related]
15. Treatment of panic disorder and agoraphobia with clonazepam.
Spier SA; Tesar GE; Rosenbaum JF; Woods SW
J Clin Psychiatry; 1986 May; 47(5):238-42. PubMed ID: 3700341
[TBL] [Abstract][Full Text] [Related]
16. Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia.
Sheehan DV
Psychiatr Clin North Am; 1985 Mar; 8(1):49-62. PubMed ID: 2859580
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of alprazolam. Therapeutic implications.
Greenblatt DJ; Wright CE
Clin Pharmacokinet; 1993 Jun; 24(6):453-71. PubMed ID: 8513649
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapeutic considerations in anxiety disorders.
Hollister LE
J Clin Psychiatry; 1986 Jun; 47 Suppl():33-6. PubMed ID: 2872208
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of tricyclic antidepressants in panic disorder.
Sweeney DR; Gold MS; Pottash AL; Martin D
Int J Psychiatry Med; 1983-1984; 13(2):93-6. PubMed ID: 6642878
[TBL] [Abstract][Full Text] [Related]
20. HPA axis disturbance and treatment outcome in panic disorder.
Coryell W; Noyes R
Biol Psychiatry; 1988 Nov; 24(7):762-6. PubMed ID: 3067754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
